Annual Report 2022 Notice of AGM & Proxy Forms
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, confirms that its Annual [...]
Accounts & AGM
Preliminary results for year to 30 June 2022
Director’s report and financial statements for the year ended 30th June 2022. To download this report as a PDF file click here.
Interim Report and Financial Statements for the 6 months to 31 December 2021
Interim Report and Financial Statements for the 6 months to 31 December 2021 To download this report as a PDF file click here.
Results of AGM
Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting (“AGM”), all resolutions put to shareholders were duly passed.
Annual Report 2021 Notice of AGM & Proxy Forms
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, confirms that its Annual [...]
Preliminary results for year to 30 June 2021
Director’s report and financial statements for the year ended 30th June 2021. To download this report as a PDF file click here
Interim Report and Accounts
Unaudited interim results for the six months ended 31st December 2020
FINAL REPORT AND ACCOUNTS
Director’s report and financial statements for the year ended 30th June 2020. To download this report as a PDF file click here.
Interim Report and Accounts
Unaudited interim results for the six months ended 31st December 2019
